AliveCor is transforming cardiological care for patients and providers. Our KardiaMobile devices are the most clinically validated personal ECGs in the world.
AliveCor introduces the world's first AI that can detect heart attack on a reduced leadset in monumental dual clearance by the FDA. Today, AliveCor launched the all-new, AI-powered Kardia 12L ECG System, which is FDA-cleared to detect 35 cardiac conditions including serious
Introducing KardiaMobile Card, the world’s first credit-card-sized personal ECG.
#KardiaMobileCard
is the thinnest, lightest, most portable device yet. Read more here:
Out of thousands of companies considered by
@FastCompany
, AliveCor has been named No.1 Most Innovative Company in Artificial Intelligence. (Last year's winner was
@Google
.) Thanks FastCompany. You're making us blush!
We’re excited to announce our expansion into India with the world’s only 6-lead personal ECG, KardiaMobile 6L. AliveCor is now offering remote heart care to the more than 250 million Indians at risk of heart disease. Learn more:
KardiaMobile is now the only personal EKG device in the world that is FDA-cleared to detect the 3 most common heart arrhythmias. In addition to Atrial Fibrillation and Normal Heart Rhythm, KardiaMobile is now able to detect Bradycardia and Tachycardia.
We are at
#ACC22
showing attendees how AliveCor is providing remote monitoring solutions at every point of care: in-clinic, at home, and on the go. Stop by booth 1613 to meet with our team and learn more.
Today we announced our acquisition of CardioLabs, a leading monitoring and cardiac diagnostic provider. This is an exciting update for us as it furthers our mission to become the premier provider of end-to-end cardiac diagnostic support.
During
#ACC22
, our Founder,
@DrDave01
, presented findings that highlight improvement of quality cardiac care in remote-patient monitoring using KardiaMobile 6L ECG. This study highlights the ways we are positively impacting health outcomes for patients and providers.
We’re proud to announce our $65 million Series E financing. This comes on the heels of tremendous growth and will help further accelerate the development of our global remote cardiology platform.
Thank you
@TechCrunch
for speaking with our CEO Priya Abani and founder
@DrDave01
. This new financing combined with the clearance of our advanced ECG determinations is a watershed moment for AliveCor.
Hear from AliveCor’s founder himself,
@DrDave01
, and get an inside look at how KardiaMobile works. Tune in to
#InnovationNation
on CBS at 12:30pm ET this Saturday 9/12.
AliveCor CEO, Priya Abani spoke at
#JPM20
about what it takes to succeed in
#digitalhealth
: “The companies that are relentlessly committed to providing the highest quality data, while protecting their customers’ data, will be the ones that win in this space.”
We’re honored to collaborate with
@AstraZeneca
on this innovative work. Our combined efforts to develop non-invasive potassium monitoring solutions has the potential to provide life-changing care for people with chronic kidney disease.
AliveCor Founder & Chief Medical Officer
@DrDave01
at today's
#AHA21
panel "AI won't replace doctors, but doctors who use AI in their practice will replace those doctors who do not."
Today we launched AliveCor Labs, a new offering for U.S. HCPs that provides reimbursed ambulatory cardiac monitoring with 24/7 data analysis & customized reporting to help inform clinical decision-making. Read more below.
#cardiology
#CardioTwitter
#GP
News: AliveCor is partnering with Huami, the world’s second largest wearable maker, to deliver the next generation of medical wearables. We’ll combine our AI and IP with Huami devices to provide meaningful and affordable heart health data worldwide.
Today, the International Trade Commission (ITC) has issued its Final Determination ruling that Apple Watch infringed AliveCor’s patented technology. Read more here:
Congratulations to our fearless leader, Priya Abani, for being named one of the 2020 Women Worth Watching. Priya’s leadership has been invaluable as we continue to navigate this year’s unknowns, and we feel lucky to benefit from it everyday.
In pts ≥55 y of age with a recent cryptogenic stroke or TIA, 30-day KardiaMobile smartphone ECG recording is superior to repeat 24-h Holter monitoring to detect AF (9.5% vs 2.0%) and to start OAC therapy (9.5% vs 0% at 3m)
@nmarrouche
@netta_doc
#Europace
Virtual
#HRS2021
continues throughout July and we want to share with you the first cardiac monitor your patients will 𝑤𝑎𝑛𝑡 to use. Please click here to schedule a demo:
#ePeeps
#CardioTwitter
Thanks Dr. Pearson. KardiaPro, our remote patient ECG and BP monitoring platform is useful in a wide range of clinical use cases, including the important ones you describe here. It also has the advantage of working with devices your patients have heard of, and often, already own.
AliveCor’s Mobile ECG With Kardia Pro Is Eliminating Any Need For Short or Long Term Cadiac Monitors For Most of My Afib patients: A Tale of Four Cardioversions
Our mission at AliveCor is to provide accessible cardiological care to those who need it most. This FDA guidance is a critical step in that mission, and we’re proud to play a part in the well-being of those fighting
#COVID19
.
In a head-to-head comparison among popular ECG devices for detection of AFib, KardiaMobile® 6L demonstrated higher cardiologist-interpreted sensitivity (98.9% vs. 95.4%, 96.2%, 95.7%). Read the study here:
Our CEO Priya Abani at
@HLTHEVENT
discussing how AliveCor’s investment in data science, and the trust we’ve built with our customers, continually raises the bar on remote cardiac monitoring and digital health.
#HLTH2021
Our CEO, Priya Abani has been named among The Healthcare Technology Report’s Top 50 Healthcare Technology CEOs. The passion and integrity with which Priya leads her team is second to none. Congratulations, Priya!
When two of Dr. Pearson’s patients experienced AFib, they sent their ECG recordings to him for review. “Both of them had rates over 120 bpm. In both cases, Kardia had easily made the diagnosis. Apple Watch would have declared these ‘inconclusive.’”
.
@DrDave01
, our Founder and Chief Medical Officer, shares his position on the importance of patent protection in The Wall Street Journal. Read more here:
The groundbreaking KardiaMobile® Card has been recognized as an honoree by
@CES
for excellence in innovation, in addition to being recognized as a winner of innovation by
@FierceHealth
. Read more:
We are honored to be among the nominees for The Galien Foundation 2021 Prix Galien Award in the category of Best Digital Health Solution. We appreciate this recognition as we continue our mission to save lives and transform cardiology.
Organizations around the world are rallying together to fight the
#coronavirus
, and AI companies may be some of the most groundbreaking. We’re proud to be included in
@Forbes
' list of AI companies that are combating the
#COVID19
pandemic.
On
#WorldHeartDay
, we reaffirm our commitment to transforming cardiology by delivering intelligent, highly-personalized heart data to clinicians and patients anytime, anywhere.
#CardioTwitter
#HeartHealth
Retired NFL players are more than 5x as likely to have atrial fibrillation compared to the general male population. Studies show that endurance and strength based athletes are both at an increased risk of AF due to greater stress on the heart.
We're proud to announce our partnership w/
@GEHealthcare
to integrate KardiaMobile 6L ECG data into the MUSE Cardiac Management System. The integration will enable efficient & timely care for patients w/i the 87% of top cardiac hospitals using GE MUSE.
“The patient was experiencing palpitations, texted me his rhythm utilizing the Kardia app, and I was able to make the diagnosis of atrial fibrillation, triaging him to emergency room evaluation. Here's the kicker, he was 2,000 miles away...”
@RizikMd
Our booth is open at
#HRS2021
! The unmatched sensor technology of our Kardia devices has been validated through more research than any other personal cardiac monitor with 160+ peer-reviewed studies to date. If you’re attending
#HRS2021
, come visit us at booth 751 for a demo.
We are honored to join this important discussion with
@_DiMeSociety
and
@DeptVetAffairs
. Please join the conversation by registering through the link below.
Today at
#ATA2022
, we announced the launch of KardiaComplete, a comprehensive cardiovascular management solution that pairs easy-to-use, medical-grade remote monitoring devices with virtual coaching and cardiologist visits. Learn more:
The Startling Truths Behind the
#1
Silent Killer of Women. I was honored to help spread the word that heart disease has a big impact on women! Anti-Aging Uncensored
AliveCor is thrilled to introduce our new Chief Technology Officer, Siva Somayajula. Siva will lead a team focused on the creation of technologies that make cardiology services simpler, more convenient and more accessible than ever before. Welcome, Siva.
We’re at
#HRS2022
sharing how we are transforming cardiac care with new, innovative heart monitoring devices and services at every stage of patient care. Visit us at booth 1951 to learn more.
We are proud to share that we have surpassed 250 million ECGs recorded on Kardia devices - touching the lives of millions. This wealth of heart data is helping us develop and train our next generation of AI algorithms to further advance cardiac care and empower even more patients
We’ve expanded our range of determinations and are now offering more heart data with better accuracy than ever. Our new suite of algorithms coupled with our LQTS work with
@MayoClinic
are redefining the bounds of personal ECG and the AI that powers it.
Kardia devices have detected over 36 million instances of AFib–the most common type of cardiac arrhythmia. On
#WorldHeartDay
, learn from our Kardia customer,
@GreerMcVay
, on how our innovative technology is vital to our customers’ heart health.
#AFibAwarenessMonth
#Arrhythmia
We are partnering with major biopharmaceutical companies to monitor patient cardiovascular safety in clinical trials. How can we work with you to ensure you have the data to keep your patients safe? Please click to schedule a discussion.
#clinicaltrials
“I think the biggest misconception is that [AFib] doesn’t happen to healthy people when, in fact, it can happen to anyone.” Learn how Olympic swimmer,
@markspitzusa
, manages AFib and heart health with KardiaMobile.
#HeartMonth
No greater expression of how we’re paving the way in cardiac care than the clearance of our new suite of algorithms. These determinations will offer unmatched accuracy on the most sophisticated AI ever brought to consumer ECG.
At AliveCor, we know mobile health (mHealth) is the way of the future, and we’re proud that
@businessinsider
recognizes KardiaMobile as one of the top mHealth solutions on the market.
High-quality medical care should exist beyond the walls of a hospital. Kardia 12L, an FDA-cleared, AI-powered ECG System, will help expand access to accurate heart data in acute settings - including resource-limited and rural areas. With its unique single cable design, Kardia 12L
Thank you
@statnews
for highlighting our dual FDA clearance of the world's first AI to detect 35 cardiac conditions, including heart attack, using a reduced leadset, alongside our innovative Kardia 12L ECG System, powered by this breakthrough AI.
I’ve been using
@AliveCor
KardiaMobile 6L to help measure QTc in
#COVID19
patients. It’s remarkable how useful this small, easy-to-use device is. Innovative technology like this is crucial to have right now and it is here to stay.
We welcome all
#HRS2021
attendees to schedule a demo to experience our KardiaMobile 6L device, offering six leads of medical-grade ECG data and three times the monitoring power of other event recorders. Visit booth 751 or click here
KardiaMobile is now available in Mexico. We’ve partnered with Inpharamo to bring affordable, accessible heart care to the estimated 1.5 million people affected by arrhythmias in Mexico. Learn more:
Introducing KardiaMobile Card, the thinnest, lightest personal EKG, and it fits in your wallet. Record accurate, medical-grade EKGs and detect common arrhythmias in seconds. With
#KardiaMobileCard
, the future of heart health is in your wallet. Shop here:
A new study from
@NIHRresearch
used KardiaMobile to help determine that lead-I ECGs may help patients with AFib receive treatment earlier and represent a cost-effective use of NHS resources. Read the full study: